The funding crisis for harm reduction

Posted in Publications

The funding crisis for harm reduction
Funding for HIV-related harm reduction programmes globally is in crisis. There can be no ‘AIDS free generation’ without targeted efforts with and for people who inject drugs. Yet funding for harm reduction falls dangerously short of estimated need. While this has been the case for some time, the situation looks set to deteriorate with changing donor policies and national government neglect.
 

Safer Injecting for NPS

Posted in Publications

NPS
Scottish Drugs Forum in conjunction with NHS Greater Glasgow & Clyde and Frontier Medical have created a new advice booklet for people injecting New Psychoative Substances (NPS). The guide is intended to inform people of the risks associated with injecting NPS, drugs commonly called legal highs, or any unidentified white powders.
 

Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations

Posted in Publications

WHO hiv
In this new consolidated guidelines document on HIV prevention, diagnosis, treatment and care for key populations, the World Health Organization brings together all existing guidance relevant to five key populations – men who have sex with men, people who inject drugs, people in prisons and other closed settings, sex workers and transgender people – and updates selected guidance and recommendations.
 

European Drug Report 2014: Trends and developments

Posted in Publications

European Drug Report 2014
How many new drugs were detected in Europe over the last year? Is cannabis getting stronger? How many Europeans have ever used an illicit drug? What are the latest drug policy developments in the region? These are just some of the questions explored in the European Drug Report: Trends and developments.
 

Two decades of successes and failures in controlling the transmission of HIV through injecting drug use in England and Wales, 1990 to 2011

Posted in Publications

Responses to injecting drug use have changed focus over the last 20 years. Prevalence and incidence of human immunodeficiency virus (HIV) among people who inject drugs (PWID) in England and Wales were examined in relation to these changes. A voluntary unlinked-anonymous surveillance study obtained a biological sample and questionnaire data from PWID through annual surveys since 1990.